I am an executive vice president of Eli Lilly and Company and the president of Lilly Neuroscience. I have held a range of leadership roles across multiple therapeutic areas, including oncology, neuroscience, and infectious disease. I have led the development of multiple late-phase opportunities and led teams in the submission, approval and launch of several new medicines. I also had the opportunity to lead Lilly’s successful effort to significantly speed drug development from target identification through launch.Previous positions include serving as a senior vice president of Eli Lilly and Company and the president of Lilly Oncology, with additional roles in R&D Leadership, and I have over 25 years of experience in the pharmaceutical industry. I also have experience in small-company pharma, having founded and led a startup company in oncology drug development.I am also a digital media spokesperson for Lilly and discuss topics related to our company, our business, and the health care environment. We operate in a highly regulated environment, and only designated employees can discuss our products or pipeline. If you need information about our products or have questions or concerns, please visit these resources: https://e.lilly/guidelines. Please note that direct or private messages may be shared with Lilly and third parties to meet legal or regulatory requirements. https://www.lilly.com/privacy.